AU9279601A - Compounds and methods for use thereof in the treatment of cancer or viral infections - Google Patents
Compounds and methods for use thereof in the treatment of cancer or viral infectionsInfo
- Publication number
- AU9279601A AU9279601A AU9279601A AU9279601A AU9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A AU 9279601 A AU9279601 A AU 9279601A
- Authority
- AU
- Australia
- Prior art keywords
- cancer
- compounds
- treatment
- methods
- viral infections
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
- C07D235/32—Benzimidazole-2-carbamic acids, unsubstituted or substituted; Esters thereof; Thio-analogues thereof
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/670,169 US6407105B1 (en) | 2000-09-26 | 2000-09-26 | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US09/670,166 US6608096B1 (en) | 2000-09-26 | 2000-09-26 | Compounds and methods for use thereof in the treatment of cancer or viral infections |
US09/670,170 US6380232B1 (en) | 2000-09-26 | 2000-09-26 | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US09/670,168 US6462062B1 (en) | 2000-09-26 | 2000-09-26 | Compounds and methods for use thereof in the treatment of cancer or viral infections |
PCT/US2001/029261 WO2002026716A2 (en) | 2000-09-26 | 2001-09-19 | Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
Publications (1)
Publication Number | Publication Date |
---|---|
AU9279601A true AU9279601A (en) | 2002-04-08 |
Family
ID=27505337
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292796A Ceased AU2001292796B2 (en) | 2000-09-26 | 2001-09-19 | Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
AU9279601A Pending AU9279601A (en) | 2000-09-26 | 2001-09-19 | Compounds and methods for use thereof in the treatment of cancer or viral infections |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001292796A Ceased AU2001292796B2 (en) | 2000-09-26 | 2001-09-19 | Benzimidazoles and methods for use thereof in the treatment of cancer or viral infections |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1330441A2 (en) |
JP (1) | JP2004509949A (en) |
AU (2) | AU2001292796B2 (en) |
CA (1) | CA2422916A1 (en) |
MX (1) | MXPA03002601A (en) |
WO (1) | WO2002026716A2 (en) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2302106T3 (en) | 2000-09-11 | 2008-07-01 | Novartis Vaccines And Diagnostics, Inc. | PROCEDURE FOR PREPARATION OF BENCIMIDAZOL-2-IL QUINOLINE DERIVATIVES. |
US6380232B1 (en) | 2000-09-26 | 2002-04-30 | The Procter & Gamble Company | Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof |
US20030144312A1 (en) * | 2001-10-30 | 2003-07-31 | Schoenhard Grant L. | Inhibitors of ABC drug transporters in multidrug resistant cancer cells |
WO2003082273A1 (en) | 2002-03-26 | 2003-10-09 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Solubilization of weak bases |
US7205412B2 (en) * | 2002-07-03 | 2007-04-17 | Samsung Electronics Co., Ltd. | Antibiotic additive and ink composition comprising the same |
AU2003288899B2 (en) | 2002-08-23 | 2009-09-03 | Novartis Vaccines And Diagnostics, Inc. | Benzimidazole quinolinones and uses thereof |
JP2004115397A (en) * | 2002-09-25 | 2004-04-15 | Fuji Photo Film Co Ltd | Liposome comprising therapeutic agent for vascular disease |
JP4954864B2 (en) * | 2004-04-01 | 2012-06-20 | カーディオム ファーマ コーポレイション | Prodrugs of ion channel modulating compounds and uses thereof |
KR101324863B1 (en) | 2005-05-17 | 2013-11-01 | 노파르티스 아게 | Methods for Synthesizing Heterocyclic Compounds |
CN102333568B (en) * | 2008-12-24 | 2016-01-20 | 比亚尔-珀特拉和Ca股份公司 | Medical compounds |
KR101064258B1 (en) * | 2008-12-29 | 2011-09-14 | 한국과학기술연구원 | Benzoarylureido compounds, and composition for prevention or treatment of neurodegenerative disease containing the same |
CN103450093A (en) * | 2013-09-06 | 2013-12-18 | 中国药科大学 | 2-aminobenzimidazoles and applications thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3399212A (en) * | 1966-05-16 | 1968-08-27 | Smith Kline French Lab | Benzimidazole ureas |
US3480642A (en) * | 1967-03-22 | 1969-11-25 | Smithkline Corp | Process for producing 2-carbalkoxyaminobenzimidazoles |
DE2253324A1 (en) * | 1972-10-31 | 1974-05-09 | Bayer Ag | 1-ALKOXYCARBONYL-2-SQUARE BRACKETS ON UP- (ALKOXYCARBONYL) -AMINO SQUARE BRACKETS FOR -BENZIMIDAZOLE, THE PROCESS FOR THEIR PRODUCTION AND THEIR USE AS FUNGICIDES |
HU177582B (en) * | 1977-10-25 | 1981-11-28 | Chinoin Gyogyszer Es Vegyeszet | Fungicide preparations containing new benzimidazole derivatives and process for preparing the active materials thereof |
ZA962879B (en) * | 1995-04-12 | 1997-03-17 | Procter & Gamble | A pharmaceutical composition for inhibiting the growth of viruses and cancers |
PE11499A1 (en) * | 1997-05-16 | 1999-03-01 | Procter & Gamble | TREATMENT OF HIV AND CANCER |
-
2001
- 2001-09-19 EP EP01973190A patent/EP1330441A2/en not_active Withdrawn
- 2001-09-19 CA CA002422916A patent/CA2422916A1/en not_active Abandoned
- 2001-09-19 WO PCT/US2001/029261 patent/WO2002026716A2/en active IP Right Grant
- 2001-09-19 JP JP2002531100A patent/JP2004509949A/en active Pending
- 2001-09-19 AU AU2001292796A patent/AU2001292796B2/en not_active Ceased
- 2001-09-19 MX MXPA03002601A patent/MXPA03002601A/en active IP Right Grant
- 2001-09-19 AU AU9279601A patent/AU9279601A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2002026716A3 (en) | 2002-07-11 |
WO2002026716A2 (en) | 2002-04-04 |
MXPA03002601A (en) | 2005-02-25 |
JP2004509949A (en) | 2004-04-02 |
CA2422916A1 (en) | 2002-04-04 |
EP1330441A2 (en) | 2003-07-30 |
AU2001292796B2 (en) | 2005-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6147401A (en) | Compositions and methods for the treatment of cancer | |
PL370029A1 (en) | 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer | |
EP1355563A4 (en) | METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES | |
IL129352A0 (en) | Benzimidazole-2- carbamates for the treatment of viral infections and cancer | |
EE05507B1 (en) | Use of rosuvastatin ZD4522) in the treatment of heterosgococcal family h percolesterolemia | |
AU2001293553A1 (en) | Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment | |
HK1061212A1 (en) | Pyranoindazoles and their use for the treatment ofglaucoma | |
GB0109414D0 (en) | Well treatment fluids and methods for the use thereof | |
AU2002346644A1 (en) | Use of fpt inhibitors and at least two antineoplastic agents in the treatment of cancer | |
AU5618501A (en) | Dihydropyrimidines and the use thereof as medicaments for the treatment of hepatitis | |
AU2001283285A1 (en) | Antimicrobial composition and methods of use in the treatment of disease | |
MXPA03008582A (en) | Agents and methods for treatment of cancer. | |
AU9279601A (en) | Compounds and methods for use thereof in the treatment of cancer or viral infections | |
SI1197485T1 (en) | Cyclobuten-dione derivatives for use in the treatment of artherosclerosis | |
PL368035A1 (en) | Compositions and methods for the treatment of cancer | |
PL356640A1 (en) | Treatment of viral infections using levovirintm | |
HUP0302738A3 (en) | Use of sarp-1 for the treatment and/or prevention of scleroderma | |
GB9930061D0 (en) | Quinolone compounds for use in treating viral infections | |
IL160722A0 (en) | Aryloxypropylamines as chemosensitizing agents in the treatment of cancer | |
EE200300057A (en) | Ingredients for the prevention and treatment of cancer | |
PL349910A1 (en) | Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections | |
AU5565401A (en) | Materials and methods for the treatment of depression | |
EP1322319A4 (en) | Use of il-8 protein modulators in the treatment of viral infections | |
AP2002002432A0 (en) | Treatment of viral infections | |
AU2002366195A8 (en) | Use of bisindolmaleimide and gemcitabine for the treatment of cancer |